Drug CombinationsDrug SynergismDrug Therapy, CombinationDrug InteractionsAntineoplastic Combined Chemotherapy ProtocolsProguanilMethenamineAntimalarialsDapsoneArtemisininsDrug TherapyAntineoplastic AgentsAtovaquoneCell Line, TumorDose-Response Relationship, DrugDrug Screening Assays, AntitumorMethylthioinosineCyclopentolateDrug AntagonismTropicamideCellophaneSulfamethoxazolePyrimethamineMefloquineDrug ResistancePharmaceutical PreparationsInhibitory Concentration 50Drug Evaluation, PreclinicalFloxuridineSulfadoxineCisplatinPyrazinesMolecular Targeted TherapyRifampinNanoconjugatesMicrobial Sensitivity TestsAmodiaquineXenograft Model Antitumor AssaysCell SurvivalAmikacinChloroquinePhentermineFluorouracilSesquiterpenesBoronic AcidsDoxorubicinNaphthoquinonesAntifungal AgentsApoptosisFluorenesPyrimidinesDeoxycytidinePiperazinesTreatment OutcomeDrug-Related Side Effects and Adverse ReactionsNiacinamideDrug Resistance, NeoplasmAntitubercular AgentsPlasmodium falciparumPharmacologyDrug Administration ScheduleTrimethoprimDrug DesignSystems BiologyNeoplasmsAmphotericin BAnti-HIV AgentsParasitic Sensitivity TestsVincristinePhenylurea CompoundsCytarabineQuinolinesMalaria, FalciparumAnti-Bacterial AgentsMedetomidineQuinazolinesDrug Resistance, MultiplePaclitaxelClinical Trials, Phase I as TopicNitroimidazolesAntiprotozoal AgentsDrug DiscoveryTime FactorsBenzenesulfonatesAntihypertensive AgentsClinical Trials as TopicPyrazinamideMice, SCIDHydroxamic AcidsAntimetabolites, AntineoplasticItraconazoleCell ProliferationTriazinesMice, NudeTaxoidsMethotrexateEtoposideSirolimusModels, BiologicalEthambutol